7c target - as a first stop, though I do see some resistance around current levels. 7c is about about $120m mkt cap. To get there, we need quarterly numbers that at least match previous qtrs of growth, news on the initial rollout of the infant app which sounds like its launching around now, news on the conclusion of testing for FDA and updated timeline for approval, and some solid news on UK rollouts. All of that needs to allow investors to see the blue sky ahead and that kind of valuation. I do think that if they get somewhere up there, they will raise again, and that would make sense for the rollout in the USA, and to have some ammo to spare.
PCK Price at posting:
4.2¢ Sentiment: Buy Disclosure: Held
